Literature DB >> 9847339

Diminished production of human immunodeficiency virus type 1 in astrocytes results from inefficient translation of gag, env, and nef mRNAs despite efficient expression of Tat and Rev.

P R Gorry1, J L Howard, M J Churchill, J L Anderson, A Cunningham, D Adrian, D A McPhee, D F Purcell.   

Abstract

Astrocytes infected with human immunodeficiency virus type 1 (HIV-1) produce only minimal quantities of virus. The molecular events that limit acute-phase HIV-1 infection of astrocytes were examined after inducing acute-phase replication by transfection with the pNL4-3 proviral plasmid. The levels of HIV-1 mRNA were similarly high in both astrocytes and HeLa cells, but astrocytes produced approximately 50-fold less supernatant p24 than HeLa cells. We found that diminished HIV-1 production in astrocytes resulted from inefficient translation of gag, env, and nef mRNAs that were efficiently transported to the cytoplasm. Tat- or Rev-dependent reporter constructs showed no defect in Tat or Rev function in astrocytes compared with HeLa cells. HIV-1 mRNAs were correctly spliced, but only Rev and Tat proteins were efficiently translated from their native mRNAs. Pulse-chase labelling and immunoblot experiments revealed no defect in protein processing, but levels of Gag, Env, or Nef protein expressed were dramatically reduced in astrocytes compared to HeLa cells. These results demonstrate that inefficient translation of HIV-1 structural proteins underlies the restricted infection of astrocytes. The efficient expression of functional Tat and Rev by astrocytes may contribute to HIV-1 neuropathogenesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9847339      PMCID: PMC103840     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Cytokine augmentation of HIV-1 LTR-driven gene expression in neural cells.

Authors:  S Swingler; A Easton; A Morris
Journal:  AIDS Res Hum Retroviruses       Date:  1992-04       Impact factor: 2.205

2.  TAR-independent activation of HIV-1 requires the activation domain but not the RNA-binding domain of Tat.

Authors:  J P Taylor; M Kundu; K Khalili
Journal:  Virology       Date:  1993-08       Impact factor: 3.616

3.  Susceptibility of primary human glial fibrillary acidic protein-positive brain cells to human immunodeficiency virus infection in vitro: anti-HIV activity of memantine.

Authors:  P G Rytik; V F Eremin; Z B Kvacheva; N N Poleschuk; S A Popov; H C Schröder; M Bachmann; B E Weiler; W E Müller
Journal:  AIDS Res Hum Retroviruses       Date:  1991-01       Impact factor: 2.205

4.  Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta.

Authors:  C Tornatore; A Nath; K Amemiya; E O Major
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

5.  Regulated expression of human immunodeficiency virus type 1 in human glial cells: induction of dormant virus.

Authors:  M Shahabuddin; B Volsky; H Kim; K Sakai; D J Volsky
Journal:  Pathobiology       Date:  1992       Impact factor: 4.342

6.  Infection of human brain cells by HIV-1: restricted virus production in chronically infected human glial cell lines.

Authors:  R Brack-Werner; A Kleinschmidt; A Ludvigsen; W Mellert; M Neumann; R Herrmann; M C Khim; A Burny; N Müller-Lantzsch; D Stavrou
Journal:  AIDS       Date:  1992-03       Impact factor: 4.177

7.  Target cells for HIV in the central nervous system: macrophages or glial cells?

Authors:  V Erfle; P Stoeckbauer; A Kleinschmidt; B Kohleisen; W Mellert; D Stavrou; R Brack-Werner
Journal:  Res Virol       Date:  1991 Mar-Jun

8.  Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1.

Authors:  J M Sabatier; E Vives; K Mabrouk; A Benjouad; H Rochat; A Duval; B Hue; E Bahraoui
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

9.  Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity.

Authors:  D F Purcell; M A Martin
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

10.  TAR-independent transactivation by Tat in cells derived from the CNS: a novel mechanism of HIV-1 gene regulation.

Authors:  J P Taylor; R Pomerantz; O Bagasra; M Chowdhury; J Rappaport; K Khalili; S Amini
Journal:  EMBO J       Date:  1992-09       Impact factor: 11.598

View more
  52 in total

Review 1.  HIV reservoirs and strategies for eradication.

Authors:  Miranda Z Smith; Fiona Wightman; Sharon R Lewin
Journal:  Curr HIV/AIDS Rep       Date:  2012-03       Impact factor: 5.071

2.  Enigma of HIV-1 latent infection in astrocytes: an in-vitro study using protein kinase C agonist as a latency reversing agent.

Authors:  Ashok Chauhan
Journal:  Microbes Infect       Date:  2015-06-02       Impact factor: 2.700

Review 3.  Genetic variation and HIV-associated neurologic disease.

Authors:  Satinder Dahiya; Bryan P Irish; Michael R Nonnemacher; Brian Wigdahl
Journal:  Adv Virus Res       Date:  2013       Impact factor: 9.937

Review 4.  HIV-1 transcriptional regulation in the central nervous system and implications for HIV cure research.

Authors:  Melissa J Churchill; Daniel J Cowley; Steve L Wesselingh; Paul R Gorry; Lachlan R Gray
Journal:  J Neurovirol       Date:  2014-07-25       Impact factor: 2.643

5.  Specific Activation In Vivo of HIV-1 by a Bromodomain Inhibitor from Monocytic Cells in Humanized Mice under Antiretroviral Therapy.

Authors:  Guangming Li; Zheng Zhang; Natalia Reszka-Blanco; Feng Li; Liqun Chi; Jianping Ma; Jerry Jeffrey; Liang Cheng; Lishan Su
Journal:  J Virol       Date:  2019-05-29       Impact factor: 5.103

6.  Low TRBP levels support an innate human immunodeficiency virus type 1 resistance in astrocytes by enhancing the PKR antiviral response.

Authors:  Chi L Ong; Janine C Thorpe; Paul R Gorry; Sylvie Bannwarth; Anthony Jaworowski; Jane L Howard; Sean Chung; Shahan Campbell; Helen S Christensen; Guerline Clerzius; Andrew J Mouland; Anne Gatignol; Damian F J Purcell
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

7.  ADAR1 interacts with PKR during human immunodeficiency virus infection of lymphocytes and contributes to viral replication.

Authors:  Guerline Clerzius; Jean-François Gélinas; Aïcha Daher; Marion Bonnet; Eliane F Meurs; Anne Gatignol
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

8.  Acetylated Tat regulates human immunodeficiency virus type 1 splicing through its interaction with the splicing regulator p32.

Authors:  Reem Berro; Kylene Kehn; Cynthia de la Fuente; Anne Pumfery; Richard Adair; John Wade; Anamaris M Colberg-Poley; John Hiscott; Fatah Kashanchi
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

9.  Macrophage-tropic HIV-1 variants from brain demonstrate alterations in the way gp120 engages both CD4 and CCR5.

Authors:  Hamid Salimi; Michael Roche; Nicholas Webb; Lachlan R Gray; Kelechi Chikere; Jasminka Sterjovski; Anne Ellett; Steve L Wesselingh; Paul A Ramsland; Benhur Lee; Melissa J Churchill; Paul R Gorry
Journal:  J Leukoc Biol       Date:  2012-10-17       Impact factor: 4.962

10.  Simian fetal brain progenitor cells for studying viral neuropathogenesis.

Authors:  Naoko Iwata; Hiroaki Yoshida; Minoru Tobiume; Fumiko Ono; Takuya Shimazaki; Tetsutaro Sata; Noriko Nakajima
Journal:  J Neurovirol       Date:  2007       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.